Immunisation against plague by transcutaneous and intradermal application of subunit antigens (Q41461132)

1 October 2017

Immunisation against plague by transcutaneous and intradermal application of subunit antigens (English)

1 reference

1 October 2017

Eyles JE

1

1 reference

1 October 2017

Elvin SJ

2

1 reference

1 October 2017

Westwood A

3

1 reference

1 October 2017

Lebutt CS

4

1 reference

1 October 2017

Alpar HO

5

1 reference

1 October 2017

Somavarapu S

6

1 reference

1 October 2017

Williamson ED

7

1 reference

1 October 2017

language of work or name

English

0 references

publication date

1 October 2004

1 reference

1 October 2017

1 reference

1 October 2017

22

1 reference

1 October 2017

4365-4373

1 reference

1 October 2017

31-32

1 reference

Yersinia pestis--etiologic agent of plague

1 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.049

Vaccination against bubonic and pneumonic plague

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.049

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.049

Yersiniosis I: microbiological and clinicoepidemiological aspects of plague and non-plague Yersinia infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.049

Vaccines against dangerous pathogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.049

Plague vaccine research and development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.049

Protection studies following bronchopulmonary and intramuscular immunisation with yersinia pestis F1 and V subunit vaccines coencapsulated in biodegradable microspheres: a comparison of efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.049

Analysis of local and systemic immunological responses after intra-tracheal, intra-nasal and intra-muscular administration of microsphere co-encapsulated Yersinia pestis sub-unit vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.049

Intra nasal administration of poly-lactic acid microsphere co-encapsulated Yersinia pestis subunits confers protection from pneumonic plague in the mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.049

Transcutaneous immunization: a human vaccine delivery strategy using a patch

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.049

A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunized animals against pneumonic plague

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.049

Microsphere translocation and immunopotentiation in systemic tissues following intranasal administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.049

Mucosally induced immunoglobulin E-associated inflammation in the respiratory tract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.049

The pulmonary environment promotes Th2 cell responses after nasal-pulmonary immunization with antigen alone, but Th1 responses are induced during instances of intense immune stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.049

Immunization onto bare skin with heat-labile enterotoxin of Escherichia coli enhances immune responses to coadministered protein and peptide antigens and protects mice against lethal toxin challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.049

Transcutaneous immunization with bacterial ADP-ribosylating exotoxins, subunits, and unrelated adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.049

Transcutaneous immunization: T cell responses and boosting of existing immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.049

Cutaneous vaccination: the skin as an immunologically active tissue and the challenge of antigen delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.049

An investigation of the intradermal route as an effective means of immunization for microparticulate vaccine delivery systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.049

Manipulating systemic and mucosal immune responses with skin-deliverable adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.049

Epidermal immunization by a needle-free powder delivery technology: Immunogenicity of influenza vaccine and protection in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.049

Improved genetic immunization via micromechanical disruption of skin-barrier function and targeted epidermal delivery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.049

10.1016/J.VACCINE.2004.02.049

7 January 2021

Identifiers

DOI

1 reference

release_ehpi3botffeenlqt64cnuy2mcu

1 October 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ehpi3botffeenlqt64cnuy2mcu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference